# Thyroid cancer

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class TD25 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Thyroid Cancer - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK459299/
- Verified date: 2026-08

## Verified against

- No dose - referral pathway, no medicine given in primary care

## Treatment metadata

- No drug therapy in primary care (Referral & Advice)

## Complete treatment card

```text
THYROID CANCER
Sources: ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class TD25 -
         condition scope only, no dose · No dose - referral pathway, no medicine given in primary
         care · Thyroid Cancer - StatPearls - NCBI Bookshelf -
         https://www.ncbi.nlm.nih.gov/books/NBK459299/
Review status: REVIEWED against the source listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (4)
    - Most patients present with a noticed neck swelling or an incidentally found thyroid nodule on
      imaging  [neck lump]
    - A concerning history includes rapid nodule growth with pressure symptoms such as voice
      hoarseness, difficulty swallowing, breathlessness, or Horner syndrome  [breathlessness ·
      difficulty swallowing · hoarseness]
    - A family history of thyroid cancer, prior childhood head or neck radiation, or systemic
      symptoms like weight loss and fatigue also raise concern  [fatigue · weight loss]
    - Anaplastic thyroid cancer instead causes a rapidly growing neck mass with quick-onset
      compressive symptoms, plus fever, weight loss, or loss of appetite  [fever · neck lump · poor
      appetite · weight loss]
  SIGNS - what you find (1)
    - A firm, fixed nodule with palpable neck lymph nodes on exam should raise suspicion for cancer
  TESTS (12)
    - Thyroid function testing is the recommended first step in evaluating any thyroid nodule
    - A hyperthyroid patient has a lower malignancy risk and should get a radionuclide uptake scan
      instead
    - Biopsy is generally avoided for a hyperfunctioning nodule because these are rarely malignant
      and biopsy results are often inaccurate
    - A euthyroid or hypothyroid nodule is evaluated first with a high-resolution thyroid ultrasound
    - High-risk ultrasound features include growth on prior imaging, a dark appearance, irregular
      margins, a taller-than-wide shape, microcalcifications, a solid structure, extension beyond
      the thyroid, and central blood flow
    - Features suggesting lower risk include a fully cystic nodule, a spongiform pattern, comet-tail
      shadowing, and blood flow only at the edges
    - Biopsy accuracy depends heavily on operator and pathologist skill, ranging from 70% to 97%,
      and 17% to 20% of samples come back insufficient
    - Biopsy diagnoses papillary cancer well but cannot confirm follicular cancer, which needs final
      surgical pathology to check for capsular or vascular invasion
    - A Bethesda Category 1 result is non-diagnostic and calls for repeat biopsy
    - Bethesda Categories 5 and 6 (suspicious or malignant) usually go straight to surgery
    - Single-mutation molecular tests like BRAF V600E have 100% specificity but only 50-60%
      sensitivity for indeterminate nodules
    - A gene expression classifier has a strong negative predictive value but only about 50%
      positive predictive value, making it a good rule-out test
  IF NOT THIS - what else fits (4)
    - Benign thyroid nodule
    - Toxic nodular goiter
    - Primary thyroid lymphoma
    - Cervical lymphadenopathy
  Source  StatPearls "Thyroid Cancer" - disease-level clinical article
  Status  traced to the source above

1. NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)    [1st line]
   Adult    Thyroid cancer requires surgical and oncologic management; the GP's role is to recognise
            a suspicious thyroid nodule and refer promptly. - Refer, with advice
   Peds     Children follow the same pathway: recognise and refer. No primary-care medicine is
            implied.
   Source   No dose - referral pathway, no medicine given in primary care
   Why      Thyroid cancer requires surgical and oncologic management; the GP's role is to recognise
            a suspicious thyroid nodule and refer promptly.
   Caution  A rapidly enlarging neck mass, hoarseness, difficulty swallowing, neck lymph node
            swelling, or a fixed hard nodule are all urgent referral triggers.
            No medicine is prescribed for this in primary care - this entry is for recognition and
            referral. Anything given is decided by the service it is referred to.
            RED FLAG - Specific features that should trigger suspicion of malignancy in a thyroid
            nodule and prompt referral, beyond generic 'suspicious nodule'
            RED FLAG - Rapidly enlarging neck mass with airway/aerodigestive compressive symptoms
            suggests anaplastic thyroid cancer, a much more urgent presentation.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
